Paul C. De Jong
Hoofddorp, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.
Journal: Nature
Published: July 22, 2025
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial.
Journal: Journal of the National Cancer Institute
Published: June 20, 2025
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial.
Journal: Journal of the National Cancer Institute
Published: June 20, 2025
Reducing administrative burden by implementing a core set of quality indicators in the ICU: a multicentre longitudinal intervention study.
Journal: BMJ quality & safety
Published: April 25, 2024
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.
Journal: Nature
Published: January 09, 2024
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.
Journal: ESMO open
Published: September 13, 2023
INCIDENCE, RISK FACTORS, AND OUTCOME OF SUSPECTED CENTRAL VENOUS CATHETER-RELATED INFECTIONS IN CRITICALLY ILL COVID-19 PATIENTS: A MULTICENTER RETROSPECTIVE COHORT STUDY.
Journal: Shock (Augusta, Ga.)
Published: September 26, 2022
Good versus bad news consultations in advanced breast cancer: the role of empathy in information recall - an observational study.
Journal: BMJ supportive & palliative care
Published: August 31, 2022
Assess and validate predictive performance of models for in-hospital mortality in COVID-19 patients: A retrospective cohort study in the Netherlands comparing the value of registry data with high-granular electronic health records.
Journal: International journal of medical informatics
Published: April 12, 2022
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Journal: Breast cancer research and treatment
Published: November 19, 2021
Last Updated: 09/26/2026